This Evidence Report and systematic review to support a 2017 US Preventive Services Task Force Recommendation Statement summarizes current evidence on benefits and harms of screening for and treatment of amblyopia, its risk factors, and refractive error in children aged 6 months to 5 years.
This randomized clinical trial compares the effects of bevacizumab vs aflibercept on visual acuity among patients with macular edema due to central retinal or hemiretinal vein occlusion.
This study reports 7-year outcomes data for patients with uveitis randomized in the Multicenter Uveitis Steroid Treatment trial to receive an intravitreous fluocinolone acetonide implant vs prednisone or other immunosuppressant therapy.
This randomized trial reports that in patients with proliferative diabetic retinopathy, ranibizumab treatment resulted in visual acuity that was noninferior to panretinal photocoagulation treatment at 2-year follow-up.
You currently have no searches saved.